BIO-RAD LABORATORIES INC.

Company Snapshot

Founded: 1952
Entity Type: Public
Employees: 7,700
Region: U.S.
Revenue: $2,566.5 Millions
Revenue Year: 2024
Segment: Life Sciences and Clinical Diagnostics
Headquarter: California, U.S.
Key Geographics: U.S., Europe, Asia, Canada, Latin America
Corporate Address: 1000 Alfred Nobel Drive, Hercules, California, 94547 U.S. Tel. +1-510-724-7000 www.bio-rad.com

Company Overview

Bio-Rad Laboratories was established in 1952 to develop biochemical and radiochemicals. Bio-Rad Laboratories designs and manufactures a range of diagnostic tools and services for research institutions, hospitals, pharmaceutical and biotechnology companies, and academic institutions. The company operates in two business segments: Life Science and Clinical Diagnostics. The life sciences category’s equipment, systems, reagents, and consumables are used to characterize, quantify, segregate, and purify biological components such as proteins, cells, and nucleic acids. Over 8,000 employees work across the globe. They include degree-holding scientists, engineers, software developers, and other technical support personnel. The company has a large direct sales force for global operations, with over 830 direct sales and sales management employees worldwide.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

BIO-RAD LABORATORIES INC. In Reports

Noninvasive Cancer Diagnostics: Technologies and Global Markets

According to BCC Research detailed report on noninvasive cancer diagnostic market global revenue ($ Million) for the base year 2024, estimated data for 2025, and forecasts through 2026-2030.

Ion Exchange Materials: Technologies and Global Markets

Our detailed report on ion exchange materials market report also analyzes the companies and regions, highlighting and elaborating on the economic factors in this marketplace.

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Our detailed report on the Central Nervous System Biomarkers Markets is segmented based on by biomarker type, technology, disease, application, and region for the forecast 2025 through 2030.

Company's Business Segments

  • Life Sciences : Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes.
  • Clinical Diagnostics : Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
  • Others : Miscellaneous operations

Applications/End User Industries

  • Academic and Research Institutions
  • Universities
  • Research Centers
  • Academic Laboratories
  • Biotechnology
  • Blood Banks and Transfusion Centers
  • Regulatory Agencies
  • Public Health Organizations
  • Contract Research Organizations
  • Clinical Laboratories
  • Medical Laboratories
  • Diagnostic Centers
  • Physician Office Laboratories
  • Pharmaceuticals
AI Sentiment